Los puntos clave no están disponibles para este artículo en este momento.
Delayed time to antimicrobial susceptibility results can impact patients' outcomes. Our study evaluated the impact of susceptibility turnaround time (TAT) and inadequate empiric antibacterial therapy (IET) in patients with bloodstream infections (BSI) caused by
Cooper et al. (Tue,) studied this question.